Imudot 800 Tablet contains Pidotimod 800 mg, an immunostimulant agent used to enhance the body’s immune response. It is primarily indicated for the prevention and treatment of recurrent respiratory tract infections, including bronchitis, sinusitis, and tonsillitis, particularly in patients with compromised or weakened immune systems. Pidotimod acts by modulating both the innate and adaptive immune responses, promoting the activation and proliferation of T-lymphocytes, and enhancing macrophage function, thereby improving the host’s defense mechanisms against infectious agents. Imudot 800 is beneficial in reducing the frequency and severity of infections and may also be used as an adjunct therapy in chronic inflammatory conditions to support immune regulation. The recommended dosage and duration of treatment should be determined by a healthcare professional based on the patient’s clinical condition. Common side effects are generally mild and may include gastrointestinal discomfort or allergic reactions. Caution is advised in patients with known hypersensitivity to Pidotimod or any excipients in the formulation. Imudot 800 Tablet should be used under medical supervision, and patients are advised to report any unusual symptoms promptly. It is not intended to replace standard antimicrobial therapy but to complement immune function during infection management.